The Joint Corporation (JYNT) - Kapitalizatsiyaning foydaga nisbati

The Joint Corp (JYNT) brendining ramzi va logotipi

The Joint Corp. (JYNT) kompaniyasining bozor kapitalizatsiyasi tendentsiyasi 32.80 qiymatini namoyish etmoqda. Biznes samaradorligi hamkorlar tarmog'ining kengayishi va tajribali tibbiy mutaxassislarning mavjudligi hamda me’yordagi ijara xarajatlariga bog'liq. Brend o'zining hamyonbop narxlari va navbatlarning yo'qligi tufayli tan olinmoqda. Naqd pullarni saqlab qolish uchun rahbariyat qimmatbaho franchayzalarni qayta sotib olishdan voz kechib, buning o'rniga klinikalarning organik o'sishiga e'tibor qaratgan.

The Joint - JYNT Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 11.11.2026)

The Joint Corporation (JYNT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:JYNT (thejoint.com)
The Joint tayyor mahsulotlari

Ushbu koeffitsient bozor kapitalizatsiyasining sof foydaga bo'linishi orqali hisoblanadi va yillik daromadning bir dollari uchun xarajatni aniqlaydi. Mazkur metrika real daromadlardan bozor shovqinlarini filtrlagan holda, investitsiyaning haqiqiy qoplash muddatini o'lchaydi. Fiksirlangan xizmat narxiga ega bo'lgan The Joint Corp. (JYNT) ning kengayuvchan franchayzi uchun ushbu hisob-kitob ommaviy talabning samaradorligini tasdiqlaydi. Kompaniyaga tegishli moliyaviy hisobotlarga asoslangan P/E koeffitsiyentini tahlil qilish orqali investor o'z portfelini o'z vaqtida qayta muvozanatlashtirishi mumkin.

Raqobatdosh kompaniyalar

Narx-foyda koeffitsiyenti HCA Holdings (HCA)|P/E multiplikatori THC|FMS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Solventum Inc. SOLV|EHC: Narx-foyda multiplikatori|UHS: Narx-foyda koeffitsiyenti|davita.com - Bozor narxining sof foydaga nisbati|RDNT (RadNet) - Narx-foyda koeffitsiyenti|OPCH: Bozor narxining sof foydaga nisbati|SGRY (Surgery Partners Corp) - P/E multiplikatori|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|PGNY - Kapitalizatsiyaning foydaga nisbati|Ardent Health Partners - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SEM|ASTH - Narxning foydaga nisbati|Pediatrix Medical - Bozor narxining sof foydaga nisbati|usph.com (USPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati pennantgroup.com (PNTG)|ORGO (Organogenesis) - P/E multiplikatori|Nutex Health Inc (NUTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Auna Health (AUNA)|SBC Medical Group Inc - Narx-foyda multiplikatori|Evolus, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CYH (chs.net)|SKIN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati MDWD (MediWound Ltd.)|BTMD: P/E multiplikatori|Narx-foyda koeffitsiyenti DocGo, Inc|Narxning foydaga nisbati P3 Health Partners, Inc.|Kapitalizatsiyaning foydaga nisbati gaintherapeutics.com GANX|Narxning foydaga nisbati EUDA Health Holdings Limited (EUDA)|BMGL (baselmedical.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CollPlant Biotechnologies Ltd. CLGN|CUPR (Cuprina Holdings Limited) - Kapitalizatsiyaning sof foydaga nisbati|CCM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati ashs.com AMS|MEDIROM Healthcare Group (MRM) - Narxning foydaga nisbati|ALBT: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti DHAI|Kapitalizatsiyaning foydaga nisbati Carmell Corp XAGE|Narxning foydaga nisbati NewGenIvf Group Limited (NIVF)|atipt.com - Narx-foyda multiplikatori|CareMax - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KDLY (Kindly MD Inc)|MODV: Narx-foyda koeffitsiyenti|Novo Integrated Sciences Corp - Bozor narxining sof foydaga nisbati|sunlinkhealth.com (SSY) - Narxning foydaga nisbati|imacholdings.comm - Kompaniya qiymatining sof foydaga nisbati